Cornerstone Advisory, LLC Aptinyx Inc. Transaction History

Cornerstone Advisory, LLC

  • $720 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 23, 2022
SELL
$2.11 - $3.0 $28,982 - $41,208
-13,736 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$2.21 - $2.89 $897 - $1,173
-406 Reduced 2.87%
13,736 $32,000
Q4 2020

May 11, 2021
BUY
$2.93 - $4.3 $41,436 - $60,810
14,142 New
14,142 $49,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Cornerstone Advisory, LLC Portfolio

Follow Cornerstone Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email